» Articles » PMID: 36588818

Calorie Restriction Remodels Gut Microbiota and Suppresses Tumorigenesis of Colorectal Cancer in Mice

Overview
Journal Exp Ther Med
Specialty Pathology
Date 2023 Jan 2
PMID 36588818
Authors
Affiliations
Soon will be listed here.
Abstract

Colorectal cancer (CRC) is one of the most common cancers worldwide and the consumption of a high-calorie diet is one of its risk factors. Calorie restriction (CR) slows tumor growth in a variety of cancers, including colorectal cancer; however, the mechanism behind this remains unknown. In the present study, CR effectively reduced the tumor volume and weight in a xenograft BALB/c male nude mouse model. In addition, tumor immunohistochemistry revealed that the CR group had significantly higher expression of Bax (P<0.001) and significantly lower levels of Bcl2 (P<0.0001) and Ki67 (P<0.001) compared with control group. Furthermore, data from 16S ribosomal (r)RNA sequencing implied that CR was able to reprogram the microbiota structure, characterized by increased constituent ratio (P<0.05), with amelioration of microbial dysbiosis caused by CRC. Further receiver operating characteristic curves demonstrated that the bacteria [area under the curve (AUC)=0.800], (AUC=0.760) and (AUC=0.720) served key roles in suppression of CRC in the mouse model. The functional prediction of intestinal flora indicated 'cyanoamino acid metabolism' (P<0.01), 'replication initiation protein REP (rolling circle plasmid replication)' (P<0.01), 'tRNA G10 N-methylase Trm11' (P<0.01) and 'uncharacterized protein with cyclophilin fold, contains DUF369 domain' (P<0.05) were downregulated in CR group. These findings implied that CR suppressed CRC in mice and altered the gut microbiota.

Citing Articles

Dietary Restrictions and Cancer Prevention: State of the Art.

Caprara G, Pallavi R, Sanyal S, Pelicci P Nutrients. 2025; 17(3).

PMID: 39940361 PMC: 11820753. DOI: 10.3390/nu17030503.


Metabolic Alteration Bridging the Prediabetic State and Colorectal Cancer.

Colloca A, Donisi I, Anastasio C, Balestrieri M, DOnofrio N Cells. 2024; 13(8.

PMID: 38667278 PMC: 11049175. DOI: 10.3390/cells13080663.


Modulation of intestinal metabolites by calorie restriction and its association with gut microbiota in a xenograft model of colorectal cancer.

Zhang Y, Dong L, Dai X, Huang Y, Gao Y, Wang F Discov Oncol. 2024; 15(1):46.

PMID: 38386206 PMC: 10884396. DOI: 10.1007/s12672-024-00897-2.


The Interplay between Medical Plants and Gut Microbiota in Cancer.

Caserta S, Genovese C, Cicero N, Toscano V, Gangemi S, Allegra A Nutrients. 2023; 15(15).

PMID: 37571264 PMC: 10421419. DOI: 10.3390/nu15153327.

References
1.
Park E, Chelvanambi M, Bhutiani N, Kroemer G, Zitvogel L, Wargo J . Targeting the gut and tumor microbiota in cancer. Nat Med. 2022; 28(4):690-703. DOI: 10.1038/s41591-022-01779-2. View

2.
Callahan B, McMurdie P, Rosen M, Han A, Johnson A, Holmes S . DADA2: High-resolution sample inference from Illumina amplicon data. Nat Methods. 2016; 13(7):581-3. PMC: 4927377. DOI: 10.1038/nmeth.3869. View

3.
Ruiz-Maso J, Machon C, Bordanaba-Ruiseco L, Espinosa M, Coll M, Del Solar G . Plasmid Rolling-Circle Replication. Microbiol Spectr. 2015; 3(1):PLAS-0035-2014. DOI: 10.1128/microbiolspec.PLAS-0035-2014. View

4.
Bradbury K, Murphy N, Key T . Diet and colorectal cancer in UK Biobank: a prospective study. Int J Epidemiol. 2019; 49(1):246-258. PMC: 7124508. DOI: 10.1093/ije/dyz064. View

5.
Perez-Lopez A, Behnsen J, Nuccio S, Raffatellu M . Mucosal immunity to pathogenic intestinal bacteria. Nat Rev Immunol. 2016; 16(3):135-48. DOI: 10.1038/nri.2015.17. View